0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Risperidone Market Report & Forecast 2022-2028
Published Date: November 2022
|
Report Code: QYRE-Auto-34S6889
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Risperidone Market Insights and Forecast to 2028
BUY CHAPTERS

Global and United States Risperidone Market Report & Forecast 2022-2028

Code: QYRE-Auto-34S6889
Report
November 2022
Pages:101
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Market Analysis and Insights: Global and United States Risperidone Market
This report focuses on global and United States Risperidone market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Risperidone market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028.

Fully considering the economic change by this health crisis, by Type, Tablet accounting for % of the Risperidone global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028.

While by Application, Schizophrenia was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Risperidone market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Risperidone Scope and Market Size
Risperidone market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Risperidone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Risperidone market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Tablet
Oral Solution

Segment by Application

Schizophrenia
Bipolar Disorder

BY REGION

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

BY COMPANY

Janssen (Johnson & Johnson)
Ajanta Pharma
Amneal Pharmaceuticals
Aurobindo Pharma
Hikma
Sandoz
Lannett
Tris Pharma
Apotex
Celltrion
Dr. Reddy's Laboratories
Torrent Pharmaceuticals
Luye Pharma Group
1 Study Coverage
1.1 Risperidone Product Introduction
1.2 Global Risperidone Outlook 2017 VS 2022 VS 2028
1.2.1 Global Risperidone Sales in US$ Million for the Year 2017-2028
1.2.2 Global Risperidone Sales in Volume for the Year 2017-2028
1.3 United States Risperidone Outlook 2017 VS 2022 VS 2028
1.3.1 United States Risperidone Sales in US$ Million for the Year 2017-2028
1.3.2 United States Risperidone Sales in Volume for the Year 2017-2028
1.4 Risperidone Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Risperidone in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Risperidone Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Risperidone Market Dynamics
1.5.1 Risperidone Industry Trends
1.5.2 Risperidone Market Drivers
1.5.3 Risperidone Market Challenges
1.5.4 Risperidone Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Risperidone Market Segment by Type
2.1.1 Tablet
2.1.2 Oral Solution
2.2 Global Risperidone Market Size by Type
2.2.1 Global Risperidone Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Risperidone Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Risperidone Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Risperidone Market Size by Type
2.3.1 United States Risperidone Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Risperidone Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Risperidone Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Risperidone Market Segment by Application
3.1.1 Schizophrenia
3.1.2 Bipolar Disorder
3.2 Global Risperidone Market Size by Application
3.2.1 Global Risperidone Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Risperidone Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Risperidone Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Risperidone Market Size by Application
3.3.1 United States Risperidone Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Risperidone Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Risperidone Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Risperidone Competitor Landscape by Company
4.1 Global Risperidone Market Size by Company
4.1.1 Top Global Risperidone Manufacturers Ranked by Revenue (2021)
4.1.2 Global Risperidone Revenue by Manufacturer (2017-2022)
4.1.3 Global Risperidone Sales by Manufacturer (2017-2022)
4.1.4 Global Risperidone Price by Manufacturer (2017-2022)
4.2 Global Risperidone Concentration Ratio (CR)
4.2.1 Risperidone Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Risperidone in 2021
4.2.3 Global Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Risperidone Manufacturing Base Distribution, Product Type
4.3.1 Global Risperidone Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Risperidone Product Type
4.3.3 Date of International Manufacturers Enter into Risperidone Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Risperidone Market Size by Company
4.5.1 Top Risperidone Players in United States, Ranked by Revenue (2021)
4.5.2 United States Risperidone Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Risperidone Sales by Players (2020, 2021 & 2022)
5 Global Risperidone Market Size by Region
5.1 Global Risperidone Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Risperidone Market Size in Volume by Region (2017-2028)
5.2.1 Global Risperidone Sales in Volume by Region: 2017-2022
5.2.2 Global Risperidone Sales in Volume Forecast by Region (2023-2028)
5.3 Global Risperidone Market Size in Value by Region (2017-2028)
5.3.1 Global Risperidone Sales in Value by Region: 2017-2022
5.3.2 Global Risperidone Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Risperidone Market Size YoY Growth 2017-2028
6.1.2 North America Risperidone Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Risperidone Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Risperidone Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Risperidone Market Size YoY Growth 2017-2028
6.3.2 Europe Risperidone Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Risperidone Market Size YoY Growth 2017-2028
6.4.2 Latin America Risperidone Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Risperidone Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Risperidone Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Janssen (Johnson & Johnson)
7.1.1 Janssen (Johnson & Johnson) Corporation Information
7.1.2 Janssen (Johnson & Johnson) Description and Business Overview
7.1.3 Janssen (Johnson & Johnson) Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Janssen (Johnson & Johnson) Risperidone Products Offered
7.1.5 Janssen (Johnson & Johnson) Recent Development
7.2 Ajanta Pharma
7.2.1 Ajanta Pharma Corporation Information
7.2.2 Ajanta Pharma Description and Business Overview
7.2.3 Ajanta Pharma Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Ajanta Pharma Risperidone Products Offered
7.2.5 Ajanta Pharma Recent Development
7.3 Amneal Pharmaceuticals
7.3.1 Amneal Pharmaceuticals Corporation Information
7.3.2 Amneal Pharmaceuticals Description and Business Overview
7.3.3 Amneal Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Amneal Pharmaceuticals Risperidone Products Offered
7.3.5 Amneal Pharmaceuticals Recent Development
7.4 Aurobindo Pharma
7.4.1 Aurobindo Pharma Corporation Information
7.4.2 Aurobindo Pharma Description and Business Overview
7.4.3 Aurobindo Pharma Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Aurobindo Pharma Risperidone Products Offered
7.4.5 Aurobindo Pharma Recent Development
7.5 Hikma
7.5.1 Hikma Corporation Information
7.5.2 Hikma Description and Business Overview
7.5.3 Hikma Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Hikma Risperidone Products Offered
7.5.5 Hikma Recent Development
7.6 Sandoz
7.6.1 Sandoz Corporation Information
7.6.2 Sandoz Description and Business Overview
7.6.3 Sandoz Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Sandoz Risperidone Products Offered
7.6.5 Sandoz Recent Development
7.7 Lannett
7.7.1 Lannett Corporation Information
7.7.2 Lannett Description and Business Overview
7.7.3 Lannett Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Lannett Risperidone Products Offered
7.7.5 Lannett Recent Development
7.8 Tris Pharma
7.8.1 Tris Pharma Corporation Information
7.8.2 Tris Pharma Description and Business Overview
7.8.3 Tris Pharma Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Tris Pharma Risperidone Products Offered
7.8.5 Tris Pharma Recent Development
7.9 Apotex
7.9.1 Apotex Corporation Information
7.9.2 Apotex Description and Business Overview
7.9.3 Apotex Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Apotex Risperidone Products Offered
7.9.5 Apotex Recent Development
7.10 Celltrion
7.10.1 Celltrion Corporation Information
7.10.2 Celltrion Description and Business Overview
7.10.3 Celltrion Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Celltrion Risperidone Products Offered
7.10.5 Celltrion Recent Development
7.11 Dr. Reddy's Laboratories
7.11.1 Dr. Reddy's Laboratories Corporation Information
7.11.2 Dr. Reddy's Laboratories Description and Business Overview
7.11.3 Dr. Reddy's Laboratories Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Dr. Reddy's Laboratories Risperidone Products Offered
7.11.5 Dr. Reddy's Laboratories Recent Development
7.12 Torrent Pharmaceuticals
7.12.1 Torrent Pharmaceuticals Corporation Information
7.12.2 Torrent Pharmaceuticals Description and Business Overview
7.12.3 Torrent Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Torrent Pharmaceuticals Products Offered
7.12.5 Torrent Pharmaceuticals Recent Development
7.13 Luye Pharma Group
7.13.1 Luye Pharma Group Corporation Information
7.13.2 Luye Pharma Group Description and Business Overview
7.13.3 Luye Pharma Group Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Luye Pharma Group Products Offered
7.13.5 Luye Pharma Group Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Risperidone Industry Chain Analysis
8.2 Risperidone Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Risperidone Distributors
8.3 Risperidone Production Mode & Process
8.4 Risperidone Sales and Marketing
8.4.1 Risperidone Sales Channels
8.4.2 Risperidone Distributors
8.5 Risperidone Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Risperidone CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Risperidone Market Trends
    Table 3. Risperidone Market Drivers
    Table 4. Risperidone Market Challenges
    Table 5. Risperidone Market Restraints
    Table 6. Global Risperidone Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Risperidone Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Risperidone Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Risperidone Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Risperidone Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Risperidone Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Risperidone Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Risperidone Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Risperidone Sales Share by Manufacturer, 2017-2022
    Table 15. Global Risperidone Price by Manufacturer (2017-2022) & (US$/Pcs)
    Table 16. Global Risperidone Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Risperidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risperidone as of 2021)
    Table 18. Top Players of Risperidone in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Risperidone Product Type
    Table 20. Date of International Manufacturers Enter into Risperidone Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Risperidone Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Risperidone Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Risperidone Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Risperidone Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Risperidone Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Risperidone Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Risperidone Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Risperidone Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Risperidone Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Risperidone Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Risperidone Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Risperidone Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Risperidone Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Risperidone Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Risperidone Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Risperidone Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Risperidone Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Risperidone Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Risperidone Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Risperidone Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Janssen (Johnson & Johnson) Corporation Information
    Table 43. Janssen (Johnson & Johnson) Description and Business Overview
    Table 44. Janssen (Johnson & Johnson) Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 45. Janssen (Johnson & Johnson) Risperidone Product
    Table 46. Janssen (Johnson & Johnson) Recent Development
    Table 47. Ajanta Pharma Corporation Information
    Table 48. Ajanta Pharma Description and Business Overview
    Table 49. Ajanta Pharma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 50. Ajanta Pharma Product
    Table 51. Ajanta Pharma Recent Development
    Table 52. Amneal Pharmaceuticals Corporation Information
    Table 53. Amneal Pharmaceuticals Description and Business Overview
    Table 54. Amneal Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 55. Amneal Pharmaceuticals Product
    Table 56. Amneal Pharmaceuticals Recent Development
    Table 57. Aurobindo Pharma Corporation Information
    Table 58. Aurobindo Pharma Description and Business Overview
    Table 59. Aurobindo Pharma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 60. Aurobindo Pharma Product
    Table 61. Aurobindo Pharma Recent Development
    Table 62. Hikma Corporation Information
    Table 63. Hikma Description and Business Overview
    Table 64. Hikma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 65. Hikma Product
    Table 66. Hikma Recent Development
    Table 67. Sandoz Corporation Information
    Table 68. Sandoz Description and Business Overview
    Table 69. Sandoz Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 70. Sandoz Product
    Table 71. Sandoz Recent Development
    Table 72. Lannett Corporation Information
    Table 73. Lannett Description and Business Overview
    Table 74. Lannett Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 75. Lannett Product
    Table 76. Lannett Recent Development
    Table 77. Tris Pharma Corporation Information
    Table 78. Tris Pharma Description and Business Overview
    Table 79. Tris Pharma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 80. Tris Pharma Product
    Table 81. Tris Pharma Recent Development
    Table 82. Apotex Corporation Information
    Table 83. Apotex Description and Business Overview
    Table 84. Apotex Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 85. Apotex Product
    Table 86. Apotex Recent Development
    Table 87. Celltrion Corporation Information
    Table 88. Celltrion Description and Business Overview
    Table 89. Celltrion Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 90. Celltrion Product
    Table 91. Celltrion Recent Development
    Table 92. Dr. Reddy's Laboratories Corporation Information
    Table 93. Dr. Reddy's Laboratories Description and Business Overview
    Table 94. Dr. Reddy's Laboratories Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 95. Dr. Reddy's Laboratories Product
    Table 96. Dr. Reddy's Laboratories Recent Development
    Table 97. Torrent Pharmaceuticals Corporation Information
    Table 98. Torrent Pharmaceuticals Description and Business Overview
    Table 99. Torrent Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 100. Torrent Pharmaceuticals Product
    Table 101. Torrent Pharmaceuticals Recent Development
    Table 102. Luye Pharma Group Corporation Information
    Table 103. Luye Pharma Group Description and Business Overview
    Table 104. Luye Pharma Group Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
    Table 105. Luye Pharma Group Product
    Table 106. Luye Pharma Group Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Risperidone Customers List
    Table 110. Risperidone Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Risperidone Product Picture
    Figure 2. Global Risperidone Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Risperidone Market Size 2017-2028 (US$ Million)
    Figure 4. Global Risperidone Sales 2017-2028 (K Pcs)
    Figure 5. United States Risperidone Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Risperidone Market Size 2017-2028 (US$ Million)
    Figure 7. United States Risperidone Sales 2017-2028 (K Pcs)
    Figure 8. United States Risperidone Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Risperidone Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Risperidone Report Years Considered
    Figure 11. Product Picture of Tablet
    Figure 12. Product Picture of Oral Solution
    Figure 13. Global Risperidone Market Share by Type in 2022 & 2028
    Figure 14. Global Risperidone Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Risperidone Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Risperidone Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Risperidone Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Risperidone Price by Type (2017-2028) & (US$/Pcs)
    Figure 19. United States Risperidone Market Share by Type in 2022 & 2028
    Figure 20. United States Risperidone Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Risperidone Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Risperidone Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Risperidone Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Risperidone Price by Type (2017-2028) & (US$/Pcs)
    Figure 25. Product Picture of Schizophrenia
    Figure 26. Product Picture of Bipolar Disorder
    Figure 27. Global Risperidone Market Share by Application in 2022 & 2028
    Figure 28. Global Risperidone Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Risperidone Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Risperidone Sales by Application (2017-2028) & (K Pcs)
    Figure 31. Global Risperidone Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Risperidone Price by Application (2017-2028) & (US$/Pcs)
    Figure 33. United States Risperidone Market Share by Application in 2022 & 2028
    Figure 34. United States Risperidone Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Risperidone Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Risperidone Sales by Application (2017-2028) & (K Pcs)
    Figure 37. United States Risperidone Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Risperidone Price by Application (2017-2028) & (US$/Pcs)
    Figure 39. North America Risperidone Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 40. North America Risperidone Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. United States Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Risperidone Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 44. Europe Risperidone Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Risperidone Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 51. Asia-Pacific Risperidone Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. China Taiwan Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Latin America Risperidone Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 62. Latin America Risperidone Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 63. Mexico Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Brazil Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Argentina Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Colombia Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Risperidone Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 68. Middle East & Africa Risperidone Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. UAE Risperidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Risperidone Value Chain
    Figure 73. Risperidone Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS